GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protalix BioTherapeutics Inc (FRA:PBDA) » Definitions » Interest Expense (Positive)

Protalix BioTherapeutics (FRA:PBDA) Interest Expense (Positive)


View and export this data going back to 2008. Start your Free Trial

What is Protalix BioTherapeutics Interest Expense (Positive)?

Interest Expense (Positive) only applies to insurance companies.


Protalix BioTherapeutics (FRA:PBDA) Business Description

Traded in Other Exchanges
Address
2 University Plaza, Suite 100, Hackensack, NJ, USA, 07601
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substance to Pfizer under its Amended Pfizer Agreement.